As per DelveInsight’s estimates, the total Dravet Syndrome incidence in the 7MM (the US, EU5 (the UK, Italy, Germany, Spain, France) and Japan) was 30,820.
The Dravet syndrome market size was estimated to be USD 79.1 Million in 2017, which is expected to increase at a significant CAGR during the study period (2017–2030) owing to pipeline #therapies to be launched in coming years. Among all the geographies studied, the United States accounted for the largest Dravet Syndrome market size.
Some of the key players in the Dravet syndrome market include Ovid Therapeutics, Takeda, Epygenix Therapeutics, Inc., PTC Therapeutics, Inc. and many others.
For more details on Dravet Syndrome Market Growth Analysis visit:
https://www.delveinsight.com/blog/dravet-syndrome-market/